Overexpression of the Transcription Factor Yin Yang 1 in Non-Hodgkin Lymphoma is associated with Chemo-Immune Resistance

A subset of patients with B-NHL initially does not respond to chemo-immunotherapies or relapses and no longer responds to further treatments. Therefore, there is an urgent need to identify underlying resistance factors and develops new targeted therapies to revers resistance.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research